Bristol-Myers and Pfizer report encouraging results for Phase II ACS trial -
Ingenuity Systems Announces Multi-Year Deal With Bristol-Myers Squibb for IPA -
BMY touches 50-day moving average at 21.66 -
www.companiesandmarkets.com: Bristol-Myers Squibb Company - SWOT Analysis -
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESC Highlights -
Bristol Myers (BMY) NewsBite - Bristol-Myers Down on Failed Drug Study -
BRISTOL-MYERS SQUIBB AND PFIZER PROVIDE UPDATE ON APIXABAN CDP -
Spreading the word about cancer care -
BMY touches 20-day moving average at 21.96 -
www.companiesandmarkets.com: Bristol-Myers Squibb - Competitive Intelligence -
BRISTOL-MYERS SQUIBB, PDL ENTER ALLIANCE TO DEVELOP MULTIPLE MYELOMA TREATMENT -
Good fences, safer turtles: Bristol-Myers Squibb effort protects threatened species -
BMY touches 20-day moving average at 22.19 -
BMY: To Present At IBC Life Sciences DDT 2008 Conference @ 17:00 ET [delayed] -
BMY: To Present At IBC Life Sciences DDT 2008 Conference @ 15:20 ET [delayed] -
BMY: To Present At IBC Life Sciences DDT 2008 Conference @ 12:00 ET [delayed] -